Bari Dane1,2, Amelia Kernizan3,4, Thomas O'Donnell5,4, Robert Petrocelli3,4, Wendy Rabbenou4,6, Sumona Bhattacharya4,6, Shannon Chang4,6, Alec Megibow3,4. 1. Department of Radiology, NYU Langone Health, 660 1st Avenue, New York, NY, 10016, USA. bari.dane@nyulangone.org. 2. Department of Gastroenterology, NYU Langone Health, 305 E 33rd Street, New York, NY, 10016, USA. bari.dane@nyulangone.org. 3. Department of Radiology, NYU Langone Health, 660 1st Avenue, New York, NY, 10016, USA. 4. Department of Gastroenterology, NYU Langone Health, 305 E 33rd Street, New York, NY, 10016, USA. 5. Siemens Healthineers, 40 Liberty Blvd, Malvern, PA, 19355, USA. 6. Overlook Medical Center, 33 Overlook Road, Suite 201, Summit, NJ, 07901, USA.
Abstract
PURPOSE: To compare terminal ileum (TI) mucosal iodine density obtained at dual-energy CT enterography (DECTE) with conventional CT interpretation and endoscopy in patients with Crohn's disease (CD). MATERIALS AND METHODS: Twenty-three CD patients (14 men; mean[SD] age:48.1[16.7] years) with endoscopy within 30 days of DECTE were retrospectively identified. An inflammatory bowel disease gastroenterologist reviewed endoscopic images. Two radiologists qualitatively assessed the presence of active TI inflammation. Mean iodine density normalized to the aorta (I%), mean absolute iodine density (I), and iodine density standard deviation (ISD) from the distal 2 cm ileum (TI) mucosa obtained using semiautomatic prototype software were compared with endoscopic assessment using Mann Whitney tests. The optimal threshold I% and I were determined from receiver operating curves (ROC). Sensitivity and specificity of conventional interpretation and determined iodine thresholds were compared using McNemar's test. Inter-reader agreement was assessed using kappa. A p < 0.05 indicated statistical significance. RESULTS: Twelve (52.1%) patients had endoscopic active inflammation. I% was 37.9[13.3]% for patients with and 21.7[7.5]% for patients without endoscopic active inflammation (p = 0.001). The optimal ROC threshold 24.6% had 100% sensitivity and 81.8% specificity (AUC = 0.909, 95% CI 0.777-1). I was 2.44[0.73]mg/mL for patients with and 1.77[1.00]mg/mL for patients without active endoscopic inflammation (p = 0.0455). The optimal ROC threshold 1.78 mg/mL I had 91.7% sensitivity and 63.6% specificity (AUC = 0.75, 95% CI 0.532-0.968). ISD was similar for patients with and without endoscopic active inflammation (0.82[0.33]mg/mL and 0.77[0.28]mg/mL, respectively, p = 0.37). Conventional interpretation sensitivity and specificity (R1/R2) were 83.3%/91.7% and 72.7%/54.5%, respectively (all p > 0.05) with moderate inter-reader agreement (Κ = 0.542[95% CI 0.0202-0.088]). CONCLUSION: Mean normalized iodine density is highly sensitive and specific for endoscopic active inflammation. DECTE could be considered as a surrogate to endoscopy in CD patients. Despite trends towards improved sensitivity and specificity compared with conventional interpretation, future larger studies are needed.
PURPOSE: To compare terminal ileum (TI) mucosal iodine density obtained at dual-energy CT enterography (DECTE) with conventional CT interpretation and endoscopy in patients with Crohn's disease (CD). MATERIALS AND METHODS: Twenty-three CD patients (14 men; mean[SD] age:48.1[16.7] years) with endoscopy within 30 days of DECTE were retrospectively identified. An inflammatory bowel disease gastroenterologist reviewed endoscopic images. Two radiologists qualitatively assessed the presence of active TI inflammation. Mean iodine density normalized to the aorta (I%), mean absolute iodine density (I), and iodine density standard deviation (ISD) from the distal 2 cm ileum (TI) mucosa obtained using semiautomatic prototype software were compared with endoscopic assessment using Mann Whitney tests. The optimal threshold I% and I were determined from receiver operating curves (ROC). Sensitivity and specificity of conventional interpretation and determined iodine thresholds were compared using McNemar's test. Inter-reader agreement was assessed using kappa. A p < 0.05 indicated statistical significance. RESULTS: Twelve (52.1%) patients had endoscopic active inflammation. I% was 37.9[13.3]% for patients with and 21.7[7.5]% for patients without endoscopic active inflammation (p = 0.001). The optimal ROC threshold 24.6% had 100% sensitivity and 81.8% specificity (AUC = 0.909, 95% CI 0.777-1). I was 2.44[0.73]mg/mL for patients with and 1.77[1.00]mg/mL for patients without active endoscopic inflammation (p = 0.0455). The optimal ROC threshold 1.78 mg/mL I had 91.7% sensitivity and 63.6% specificity (AUC = 0.75, 95% CI 0.532-0.968). ISD was similar for patients with and without endoscopic active inflammation (0.82[0.33]mg/mL and 0.77[0.28]mg/mL, respectively, p = 0.37). Conventional interpretation sensitivity and specificity (R1/R2) were 83.3%/91.7% and 72.7%/54.5%, respectively (all p > 0.05) with moderate inter-reader agreement (Κ = 0.542[95% CI 0.0202-0.088]). CONCLUSION: Mean normalized iodine density is highly sensitive and specific for endoscopic active inflammation. DECTE could be considered as a surrogate to endoscopy in CD patients. Despite trends towards improved sensitivity and specificity compared with conventional interpretation, future larger studies are needed.
Authors: Sunil Samuel; David H Bruining; Edward V Loftus; Brenda Becker; Joel G Fletcher; Jayawant N Mandrekar; Alan R Zinsmeister; William J Sandborn Journal: Clin Gastroenterol Hepatol Date: 2012-04-10 Impact factor: 11.382
Authors: Dan Turner; Amanda Ricciuto; Ayanna Lewis; Ferdinando D'Amico; Jasbir Dhaliwal; Anne M Griffiths; Dominik Bettenworth; William J Sandborn; Bruce E Sands; Walter Reinisch; Jürgen Schölmerich; Willem Bemelman; Silvio Danese; Jean Yves Mary; David Rubin; Jean-Frederic Colombel; Laurent Peyrin-Biroulet; Iris Dotan; Maria T Abreu; Axel Dignass Journal: Gastroenterology Date: 2021-02-19 Impact factor: 22.682
Authors: Lauren E Cipriano; Barrett G Levesque; Gregory S Zaric; Edward V Loftus; William J Sandborn Journal: Inflamm Bowel Dis Date: 2011-09-16 Impact factor: 5.325
Authors: Miguel Regueiro; Kevin E Kip; Wolfgang Schraut; Leonard Baidoo; Antonia R Sepulveda; Marilyn Pesci; Sandra El-Hachem; Janet Harrison; David Binion Journal: Inflamm Bowel Dis Date: 2011-01 Impact factor: 5.325
Authors: David H Bruining; Hassan A Siddiki; Joel G Fletcher; William J Sandborn; Jeff L Fidler; James E Huprich; Jayawant N Mandrekar; William S Harmsen; Paul E Evans; William A Faubion; Karen A Hanson; Steven B Ingle; Darrell S Pardi; Kenneth W Schroeder; William J Tremaine; Edward V Loftus Journal: Inflamm Bowel Dis Date: 2011-02-17 Impact factor: 5.325
Authors: Laurent Peyrin-Biroulet; Walter Reinisch; Jean-Frederic Colombel; Gerassimos J Mantzaris; Asher Kornbluth; Robert Diamond; Paul Rutgeerts; Linda K Tang; Freddy J Cornillie; William J Sandborn Journal: Gut Date: 2013-08-23 Impact factor: 23.059
Authors: Entcho Klenske; Christian Bojarski; Maximilian Waldner; Timo Rath; Markus F Neurath; Raja Atreya Journal: Therap Adv Gastroenterol Date: 2019-06-14 Impact factor: 4.409